SNT 3.33% 3.1¢ syntara limited

re: Ann: Pharmaxis Announces Positive Combine... And we must...

  1. 163 Posts.
    re: Ann: Pharmaxis Announces Positive Combine... And we must also keep in mind that a second phase 3 trial is currently active for the use of Bronchitol for bronchiectasis.

    There are approx. 600,000 sufferers worldwide with no drug currently proven effective to clear mucus.

    Although this trial is not expected to release data until 2012, there is the potential that with a favourable outcome Bronchitol would be approved for this indication as well.

    The potential really is great for this medication.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $40.00M
Open High Low Value Volume
3.0¢ 3.1¢ 3.0¢ $16.17K 538.6K

Buyers (Bids)

No. Vol. Price($)
3 366566 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 422617 4
View Market Depth
Last trade - 15.57pm 06/09/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.